2-chloro-N-(2,3-dihydro-1H-inden-1-yl)acetamide | 6514-50-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 2-chloro-N-(2,3-dihydro-1H-inden-1-yl)acetamide
• CAS: 6514-50-7
• 化学式: C₁₁H₁₂ClNO
• 分子量: 209.675
• InChiKey: PXOJBWMHNNIZLL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-chloro-N-(2,3-dihydro-1H-inden-1-yl)acetamide 在 羟胺 、 potassium carbonate 、 sodium hydroxide 作用下， 以 甲醇 、 水 、 丙酮 为溶剂， 生成 2,2'-((6-(hydroxyamino)-6-oxohexyl)azanediyl)bis(N-(2,3-dihydro-1H-inden-1-yl)acetamide)
  参考文献：
  名称：

  [EN] PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
  [FR] DÉRIVÉS BENZÉNIQUES À CHAÎNES ALKYLE ET ALCÉNYLE PÉRIPHÉRIQUES ÉTENDUES ET COMPOSITION PHARMACEUTIQUE COMPRENANT CEUX-CI

  摘要：

  由公式（I）代表的化合物是外周烷基和烯基链延伸的苯衍生物，可作为双重自动税林(ATX) / 组蛋白去乙酰化酶(HDAC)抑制剂而有用。这些化合物可以与药学上可接受的载体一起组成药物组合物，并以治疗有效量用于预防或治疗各种疾病和疾病。

  公开号：

  WO2020205455A1
• 作为产物：
  描述：

  1-茚酮肟 在 sodium 、 sodium carbonate 作用下， 以 戊醇 、 丙酮 为溶剂， 反应 2.0h， 生成 2-chloro-N-(2,3-dihydro-1H-inden-1-yl)acetamide
  参考文献：
  名称：

  用氰化物离子诱捕代谢产生的亲电子物质：1-苄基吡咯烷的代谢。

  摘要：

  1-苄基吡咯烷（4），特别是氘标记的4的类似物与氰化物离子存在下的兔肝微粒体制剂的孵育导致了1-苄基-2-氰基吡咯烷（13），顺式和反式-1的表征-苄基-2，5-二氰基吡咯烷（分别为14a和14b）和1-苄基-5-氰基-2-吡咯烷酮（15）。认为胺的氰基加合物是由氰化物离子对代谢产生的亚胺类物质的亲核攻击产生的。氰基内酰胺可以通过二氰基化合物的混合功能氧化来制备。rabbit标记的1-苄基吡咯烷与兔肝微粒体制剂的孵育导致烟酰胺腺嘌呤二核苷酸磷酸酯的依赖性烟碱减少，从而使标记掺入从孵育后分离的大分子级分中。尽管掺入水平比形成的氰基加合物的水平低，但与报道的其他代谢活化细胞毒性剂的水平相当。尝试确定可能的芳烃氧化物重排产物1-（4-羟基苄基）吡咯烷（24）为4的代谢物，但未成功。结果促使我们推测代谢产生的亚胺离子能够使存在于微粒体大分子上的亲核官能团烷基化。

  DOI：

  10.1021/jm00176a006

文献信息

• [EN] QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS<br/>[FR] ANALOGUES DE QUINAZOLINONE ET UTILISATION D'ANALOGUES DE QUINAZOLINONE POUR LE TRAITEMENT OU LA PRÉVENTION DE CERTAINES INFECTIONS VIRALES
  申请人：SOUTHERN RES INST

  公开号：WO2013025508A1

  公开（公告）日：2013-02-21

  Provided is a process for treating or preventing a viral infection in a subject, wherein the viral infection is from a flavivirus selected from the group consisting of Hepatitis C Virus (genotypes 1-7) and Japanese Encephalitis Virus. The process includes administering to the subject a therapeutically effective amount of at least one compound represented by the formula:(Formula (I))

  提供了一种用于治疗或预防受试者体内来自黄病毒组中选定的黄色病毒感染的方法，所述黄色病毒包括丙型肝炎病毒（基因型1-7）和日本脑炎病毒。该过程包括向受试者施用至少一种由公式（I）表示的化合物的治疗有效量。
• Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections
  申请人：Southern Research Institute

  公开号：US10611733B2

  公开（公告）日：2020-04-07

  Provided is a method for treating or preventing a viral infection in a subject, wherein the viral infection is from a flavivirus selected from the group consisting of Hepatitis C Virus (genotypes 1-7) and Japanese Encephalitis Virus, as well as novel compounds that are useful in the method.

  本发明提供了一种治疗或预防受试者病毒感染的方法，其中病毒感染来自选自丙型肝炎病毒（基因型 1-7）和日本脑炎病毒的黄病毒，以及在该方法中有用的新型化合物。
• Structural and biochemical study on the inhibitory activity of derivatives of 5-nitro-furan-2-carboxylic acid for RNase H function of HIV-1 reverse transcriptase
  作者：Hiroshi Yanagita、Emiko Urano、Kishow Matsumoto、Reiko Ichikawa、Yoshihisa Takaesu、Masakazu Ogata、Tsutomu Murakami、Hongui Wu、Joe Chiba、Jun Komano、Tyuji Hoshino

  DOI：10.1016/j.bmc.2010.12.011

  日期：2011.1

  Rapid emergence of drug-resistant variants is one of the most serious problems in chemotherapy for HIV-1 infectious diseases. Inhibitors acting on a target not addressed by approved drugs are of great importance to suppress drug-resistant viruses. HIV-1 reverse transcriptase has two enzymatic functions, DNA polymerase and RNase H activities. The RNase H activity is an attractive target for a new class of antiviral drugs. On the basis of the hit chemicals found in our previous screening with 20,000 small molecular-weight compounds, we synthesized derivatives of 5-nitro-furan-2-carboxylic acid. Inhibition of RNase H enzymatic activity was measured in a biochemical assay with real-time monitoring of florescence emission from the digested RNA substrate. Several derivatives showed higher inhibitory activities that those of the hit chemicals. Modulation of the 5-nitro-furan-2-carboxylic moiety resulted in a drastic decrease in inhibitory potency. In contrast, many derivatives with modulation of other parts retained inhibitory activities to varying degrees. These findings suggest the binding mode of active derivatives, in which three oxygen atoms aligned in a straight form at the nitro-furan moiety are coordinated to two divalent metal ions located at RNase H reaction site. Hence, the nitro-furan-carboxylic moiety is one of the critical scaffolds for RNase H inhibition. Of note, the RNase H inhibitory potency of a derivative was improved by 18-fold compared with that of the original hit compound, and no significant cytotoxicity was observed for most of the derivatives showing inhibitory activity. Since there is still much room for modification of the compounds at the part opposite the nitro-furan moiety, further chemical conversion will lead to improvement of compound potency and specificity. (C) 2010 Elsevier Ltd. All rights reserved.
• ARMSTRONG, DANIEL W.;LI, WEIYONG;STALCUP, APRYLL M.;SECOR, HENRY V.;IZAC,+, ANAL. CHIM. ACTA , 234,(1990) N, C. 365-380
  作者：ARMSTRONG, DANIEL W.、LI, WEIYONG、STALCUP, APRYLL M.、SECOR, HENRY V.、IZAC,+

  DOI：——

  日期：——
• US20140256753A1
  申请人：——

  公开号：——

  公开（公告）日：——